Early discharge program for high-dose chemo patients
Part of Blood & lymphatic, Cancer clinical trials.
This trial tests whether people with blood cancers who receive high-dose chemotherapy can safely go home earlier with a hospital-at-home program. It aims to find out if this approach is safe and feasible.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a blood cancer and are scheduled for high-dose chemotherapy (with or without stem cell transplant).
- You are between 18 and 75 years old.
- You are able to care for yourself (WHO performance status 0 or 1, or Karnofsky score 60% or higher).
- Your heart, kidney, and liver function are adequate (specific lab results are needed).
- You have a caregiver who is vaccinated against COVID-19 and can be with you 24/7 for the first days home.
- Your home is within 45 minutes' drive from the hospital.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial offers red blood cell or platelet transfusions at home for people with blood cancer who are no longer responding to treatment. It aims to improve comfort and quality of life by avoiding hospital visits.
This trial tests whether it is safe to give blood transfusions at home instead of in the hospital. It is for people who need regular blood transfusions for their cancer care.
This trial tests if people with a mild heart attack can go home early (within 48 hours) and be monitored virtually instead of staying in the hospital. It aims to make recovery more comfortable while ensuring safety.
This trial tests a program where an advanced practice nurse coordinates your care while you take oral cancer medication at home. You might benefit if you want extra check-ins by phone and are comfortable with two nurse visits at home over six months.
This Phase 2 trial compares giving certain standard cancer infusions at home versus in a clinic. It may help people avoid clinic visits while still receiving the same cancer treatment safely.
This trial tests a home-based rehabilitation program using phone or video sessions to help people with lymphoma or myeloma recover better after CAR-T cell therapy. It aims to improve physical function and quality of life during treatment.
Hear when a new Haematological Malignancy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.